These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


108 related items for PubMed ID: 2464101

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H, Smith BA, Lefer AM.
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [Abstract] [Full Text] [Related]

  • 6. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H, Smith BA, Lefer AM.
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [Abstract] [Full Text] [Related]

  • 7. Salutary consequences of blockade of platelet activating factor in hemorrhagic shock.
    Stahl GL, Bitterman H, Terashita Z, Lefer AM.
    Eur J Pharmacol; 1988 May 10; 149(3):233-40. PubMed ID: 3409951
    [Abstract] [Full Text] [Related]

  • 8. Mechanisms of action of PGE1 in hemorrhagic shock in rats.
    Bitterman H, Stahl GL, Terashita Z, Lefer AM.
    Ann Emerg Med; 1988 May 10; 17(5):457-62. PubMed ID: 3364825
    [Abstract] [Full Text] [Related]

  • 9. Beneficial effect of anisodamine in hemorrhagic shock.
    Su J, Hock CE, Lefer AM.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Apr 10; 325(4):360-5. PubMed ID: 6728045
    [Abstract] [Full Text] [Related]

  • 10. Beneficial actions of RO 15-1788, a benzodiazepine receptor antagonist, in hemorrhagic shock.
    Bitterman H, Lefer DJ, Lefer AM.
    Methods Find Exp Clin Pharmacol; 1987 Jun 10; 9(6):341-7. PubMed ID: 3116357
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Anti-shock actions of a new converting enzyme inhibitor, enalaprilic acid, in hemorrhagic shock in cats.
    Freeman JG, Hock CE, Edmonds JS, Lefer AM.
    J Pharmacol Exp Ther; 1984 Dec 10; 231(3):610-5. PubMed ID: 6094795
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Potentiation of the protective effects of a converting enzyme inhibitor and a thromboxane synthetase inhibitor in hemorrhagic shock.
    Bitterman H, Phillips GR, Dragon G, Lefer AM.
    J Pharmacol Exp Ther; 1987 Jul 10; 242(1):8-14. PubMed ID: 3039116
    [Abstract] [Full Text] [Related]

  • 15. Use of hypertonic saline in the treatment of hemorrhagic shock.
    Bitterman H, Triolo J, Lefer AM.
    Circ Shock; 1987 Jul 10; 21(4):271-83. PubMed ID: 3581442
    [Abstract] [Full Text] [Related]

  • 16. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA, Lefer AM.
    Prostaglandins Leukot Med; 1986 Dec 10; 25(2-3):175-85. PubMed ID: 2434958
    [Abstract] [Full Text] [Related]

  • 17. Effects of prostacyclin and taprostene in splanchnic artery occlusion shock.
    VanAntwerp DR, Hedley LR, Spires DA, Strosberg AM, Johnson G, Lefer AM.
    Eicosanoids; 1991 Dec 10; 4(1):15-20. PubMed ID: 2059456
    [Abstract] [Full Text] [Related]

  • 18. Salutary effects of prostacyclin in endotoxic shock.
    Lefer AM, Tabas J, Smith EF.
    Pharmacology; 1980 Dec 10; 21(3):206-12. PubMed ID: 6997895
    [Abstract] [Full Text] [Related]

  • 19. Prostacyclin (epoprostenol): its effect on canine splanchnic blood flow during hemorrhagic shock.
    Seelig RF, Kerr JC, Hobson RW, Machiedo GW.
    Arch Surg; 1981 Apr 10; 116(4):428-30. PubMed ID: 7011256
    [Abstract] [Full Text] [Related]

  • 20. Beneficial actions of nalorphine during hemorrhagic shock in cats.
    Hock CE, Curtis MT, Jaffe JS, Lefer AM.
    Proc Soc Exp Biol Med; 1983 May 10; 173(1):76-81. PubMed ID: 6304745
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.